Masayoshi Ijichi

901 total citations
23 papers, 670 citations indexed

About

Masayoshi Ijichi is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Masayoshi Ijichi has authored 23 papers receiving a total of 670 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 11 papers in Oncology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Masayoshi Ijichi's work include Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers). Masayoshi Ijichi is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers). Masayoshi Ijichi collaborates with scholars based in Japan. Masayoshi Ijichi's co-authors include Masatoshi Makuuchi, Tadatoshi Takayama, Kiyoshi Hasegawa, Norihiro Kokudo, Hiroshi Imamura, Yasutsugu Bandai, Masayuki Matsumura, Yutaka Matsuyama, Yasushi Shiratori and Masao Omata and has published in prestigious journals such as PLoS ONE, Hepatology and The American Journal of Gastroenterology.

In The Last Decade

Masayoshi Ijichi

20 papers receiving 659 citations

Peers

Masayoshi Ijichi
Masayoshi Ijichi
Citations per year, relative to Masayoshi Ijichi Masayoshi Ijichi (= 1×) peers J. Balsells

Countries citing papers authored by Masayoshi Ijichi

Since Specialization
Citations

This map shows the geographic impact of Masayoshi Ijichi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masayoshi Ijichi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masayoshi Ijichi more than expected).

Fields of papers citing papers by Masayoshi Ijichi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masayoshi Ijichi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masayoshi Ijichi. The network helps show where Masayoshi Ijichi may publish in the future.

Co-authorship network of co-authors of Masayoshi Ijichi

This figure shows the co-authorship network connecting the top 25 collaborators of Masayoshi Ijichi. A scholar is included among the top collaborators of Masayoshi Ijichi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masayoshi Ijichi. Masayoshi Ijichi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Komeno, Yukiko, et al.. (2022). Atypical Splenic Abscesses Due to Clostridioides difficile. American Journal of Case Reports. 23. e936528–e936528. 3 indexed citations
2.
Kokudo, Takashi, Akio Saiura, Tadatoshi Takayama, et al.. (2021). Adjuvant chemotherapy can prolong recurrence-free survival but did not influence the type of recurrence or subsequent treatment in patients with colorectal liver metastases. Surgery. 170(4). 1151–1154. 13 indexed citations
3.
Hasegawa, Kiyoshi, Akio Saiura, Tadatoshi Takayama, et al.. (2016). Adjuvant Oral Uracil-Tegafur with Leucovorin for Colorectal Cancer Liver Metastases: A Randomized Controlled Trial. PLoS ONE. 11(9). e0162400–e0162400. 80 indexed citations
4.
Shibasaki, Masayuki, et al.. (2015). [A Case of Effective Whole-Brain Irradiation and Lapatinib/Capecitabine Combination Therapy for HER2-Positive Breast Cancer with Multiple Brain Metastases].. PubMed. 42(6). 755–7. 2 indexed citations
5.
Saiura, Akio, Junji Yamamoto, Kiyoshi Hasegawa, et al.. (2014). A combination of oral uracil-tegafur plus leucovorin (UFT + LV) is a safe regimen for adjuvant chemotherapy after hepatectomy in patients with colorectal cancer: Safety report of the UFT/LV study. Drug Discoveries & Therapeutics. 8(1). 48–56. 13 indexed citations
6.
Togashi, Junichi, Yasuhiko Sugawara, Nobuhisa Akamatsu, et al.. (2013). Resection of a methicillin-resistant Staphylococcus aureus liver abscess in a patient with Crohn’s disease under infliximab treatment: a case report. Journal of Medical Case Reports. 7(1). 36–36. 9 indexed citations
7.
Miura, Hideaki, Masayoshi Ijichi, Yukio Ando, et al.. (2013). A rapidly progressive and fatal case of nonalcoholic steatohepatitis following pancreaticoduodenectomy. Clinical Journal of Gastroenterology. 6(6). 470–475. 16 indexed citations
8.
Ishizawa, Takeaki, Junichi Kaneko, Yosuke Inoue, et al.. (2011). Application of fluorescent cholangiography to single-incision laparoscopic cholecystectomy. Surgical Endoscopy. 25(8). 2631–2636. 52 indexed citations
9.
Ryu, Tomiko, Tsuyoshi Shirai, Masayoshi Ijichi, et al.. (2011). Peripheral T-cell Lymphoma that Developed During the Follow-Up of IgG4-Related Disease. Internal Medicine. 50(2). 155–160. 26 indexed citations
10.
Harada, Nobuhiro, Takeaki Ishizawa, Masayoshi Ijichi, et al.. (2010). Fluorescence Navigation Hepatectomy by Visualization of Localized Cholestasis from Bile Duct Tumor Infiltration. Journal of the American College of Surgeons. 210(6). e2–e6. 44 indexed citations
11.
Shibasaki, Masayuki, et al.. (2009). A Clinical Study of Gastroduodenal Crohn's Disease Which Requires Operation. The Japanese Journal of Gastroenterological Surgery. 42(1). 1–9.
12.
Shibasaki, Masayuki, et al.. (2008). A Case of Traumatic Injury of Pancreas which Requires Longitudinal Pancreaticojejunostomy due to Anastomotic Stenosis after Pancreatic Fistulojejunostomy. The Japanese Journal of Gastroenterological Surgery. 41(2). 212–217. 1 indexed citations
13.
Hasegawa, Kiyoshi, Hiroshi Imamura, Masayoshi Ijichi, et al.. (2008). Inclusion of Tumor Markers Improves the Correlation of the Milan Criteria with Vascular Invasion and Tumor Cell Differentiation in Patients with Hepatocellular Carcinoma Undergoing Liver Resection (#JGSU-D-07–00462). Journal of Gastrointestinal Surgery. 12(5). 858–866. 15 indexed citations
14.
Hasegawa, Kiyoshi, Tadatoshi Takayama, Masayoshi Ijichi, et al.. (2006). Uracil‐tegafur as an adjuvant for hepatocellular carcinoma. Hepatology. 44(4). 891–895. 61 indexed citations
15.
Hasegawa, Kiyoshi, Keiichi Kubota, Hiroshige Itakura, et al.. (2003). Effect of Apolipoprotein E Polymorphism on Bile Lipid Composition and The Formation of Cholesterol Gallstone. The American Journal of Gastroenterology. 98(7). 1605–1609. 22 indexed citations
16.
Ijichi, Masayoshi, Tadatoshi Takayama, Masayuki Matsumura, et al.. (2002). α-Fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: A prospective study. Hepatology. 35(4). 853–860. 84 indexed citations
17.
Ijichi, Masayoshi, Masatoshi Makuuchi, Hiroshi Imamura, & Tadatoshi Takayama. (2001). Portal embolization relieves persistent jaundice after complete biliary drainage. Surgery. 130(1). 116–118. 29 indexed citations
18.
Ijichi, Masayoshi. (2000). Randomized Trial of the Usefulness of a Bile Leakage Test During Hepatic Resection. Archives of Surgery. 135(12). 1395–1395. 107 indexed citations
19.
Midorikawa, Yutaka, Keiichi Kubota, Tadatoshi Takayama, et al.. (1999). A comparative study of postoperative complications after hepatectomy in patients with and without chronic liver disease. Surgery. 126(3). 484–491. 80 indexed citations
20.
Midorikawa, Yutaka, Keiichi Kubota, Tadatoshi Takayama, et al.. (1999). A comparative study of postoperative complications after hepatectomy in patients with and without chronic liver disease. Surgery. 126(3). 484–491. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026